Table 3.
Clinical features of 12 HCC patients associated with BCS.
| Pt# | Age | Sex | Duration of symptoms (months) | HBV/HCV | Child-Pugh | AFP(ng/ml) | Site of obstruction |
|---|---|---|---|---|---|---|---|
| 1 | 35 | M | 8 | -/- | A | 249 | IVC |
| 2 | 51 | F | NA | -/- | A | – | IVC+HV |
| 3 | 35 | M | NA | -/- | B | 7.9 | IVC |
| 4 | 46 | M | 5 | -/- | C | 3.8 | IVC |
| 5 | 48 | M | 40 | -/- | A | 20643 | IVC |
| 6 | 48 | M | 19 | -/- | A | 63.3 | IVC |
| 7 | 43 | F | NA | -/- | B | 1639 | IVC |
| 8 | 54 | M | NA | +/- | A | – | IVC+HV |
| 9 | 68 | F | 3 | -/- | A | 30.1 | IVC |
| 10 | 70 | M | 34 | -/- | C | 500 | IVC |
| 11 | 61 | M | 10 | -/- | A | 122.5 | IVC |
| 12 | 45 | M | NA | -/- | C | 10.3 | IVC |
Pt#, patient number; NA, not available; HBV, hepatitis B virus; HCV, hepatitis C virus; AFP, a-fetal protein; IVC, inferior vena cava; HV, hepatic vein.